Intelligent Bio Solutions Inc.
INBS
$2.36
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.86M | -2.68M | -2.98M | -3.09M | -2.54M |
| Total Depreciation and Amortization | 290.40K | 281.90K | 303.40K | 306.20K | 296.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.20K | 91.20K | 409.70K | 269.80K | -900.00 |
| Change in Net Operating Assets | -1.71M | 737.00K | -576.90K | 304.20K | -507.80K |
| Cash from Operations | -4.33M | -1.57M | -2.85M | -2.21M | -2.76M |
| Capital Expenditure | 12.90K | -68.20K | -70.40K | -208.50K | -14.40K |
| Sale of Property, Plant, and Equipment | 0.00 | 40.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 12.90K | -28.10K | -70.40K | -208.50K | -14.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.44M | 674.70K | 3.56M | 602.00K | 3.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.44M | 674.70K | 3.56M | 602.00K | 3.32M |
| Foreign Exchange rate Adjustments | 600.00 | 1.20K | -700.00 | 29.30K | 13.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.12M | -919.70K | 640.20K | -1.79M | 564.90K |